MiNK Therapeutics
(NASDAQ:INKT)
$0.9799
0.0298[3.14%]
At close: Apr 29
$0.9799
0[0.00%]
PreMarket: 5:43PM EDT

MiNK Therapeutics Stock (NASDAQ:INKT), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No data available to display
Date Announced
ticker
Company Name
Period
Period Year
Min EPS
Max EPS
Estimate
Min Rev
Max Rev
Revenue Estimate
Get Alert

FAQ

Q

What is the most recent guidance for MiNK Therapeutics (INKT)?

A

There have been no specific sales or earnings guidance reported for MiNK Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch